Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | SCHEDULE 13D/A: Others
Biorestorative Therapies | SCHEDULE 13D/A: Others
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Director Williams Patrick F.
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Director Rosa David A
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Director Kukekov Nickolay V.
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Kristal Robert Eugene
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Officer ALSTODT LANCE
Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Silva Francisco
Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | SCHEDULE 13G/A: Others
Biorestorative Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
Biorestorative Therapies | 10-Q: Q3 2024 Earnings Report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 8-K: Current report
Biorestorative Therapies | 424B5: Prospectus